|
NL127995C
(https=)
|
1963-12-20 |
|
Geigy Ag J R |
|
|
US3341538A
(en)
|
1965-06-18 |
1967-09-12 |
Geigy Chem Corp |
Certain 2, 6-methano-3-benzazocines
|
|
DE1801556A1
(de)
|
1968-10-05 |
1970-05-21 |
Huels Chemische Werke Ag |
Verfahren zur Herstellung von substituierten Hexahydropyrimidinonen-(2)
|
|
US3681349A
(en)
|
1970-03-05 |
1972-08-01 |
Morton Norwich Products Inc |
1-(substituted benzyl) tetrahydro-2-(1h) pyrimidones
|
|
US4136162A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4136145A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
CA2023492A1
(en)
|
1989-08-31 |
1991-03-01 |
Barry Clifford Lange |
Herbicidal glutarimides
|
|
US5393735A
(en)
|
1990-08-09 |
1995-02-28 |
Rohm And Haas Company |
Herbicidal glutarimides
|
|
US5098916A
(en)
|
1990-03-29 |
1992-03-24 |
G. D. Searle & Co. |
Propanobicyclic amine derivatives for cns disorders
|
|
EP0454444A1
(en)
|
1990-04-24 |
1991-10-30 |
Nissan Chemical Industries Ltd. |
Glutarimide derivatives and herbicides
|
|
US5089506A
(en)
|
1990-04-30 |
1992-02-18 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for cns disorders
|
|
US5215992A
(en)
|
1990-04-30 |
1993-06-01 |
G. D. Searle & Co. |
Ethanobicyclic amine derivatives for CNS disorders
|
|
DK204291D0
(da)
|
1991-12-20 |
1991-12-20 |
Novo Nordisk As |
Heterocykliske forbindelser deres fremstilling og anvendelse
|
|
CA2049244A1
(en)
|
1990-08-16 |
1992-02-17 |
Steven H. Christiansen |
Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom
|
|
CA2093798C
(en)
|
1990-10-10 |
2000-02-01 |
John J. Piwinski |
Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
|
|
GB9023583D0
(en)
|
1990-10-30 |
1990-12-12 |
Beecham Group Plc |
Novel compounds
|
|
BR9206623A
(pt)
|
1991-10-11 |
1995-05-02 |
Du Pont Merck Pharma |
Uréias cíclicas e análogas úteis como inibidoras da protease retroviral
|
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
|
HU220601B1
(hu)
|
1992-04-30 |
2002-03-28 |
Taiho Pharmaceutical Co. Ltd. |
Fenoxi-alkil-oxazolidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
JPH0753721B2
(ja)
|
1992-09-11 |
1995-06-07 |
工業技術院長 |
環状ウレタン化合物の製造法
|
|
GB9225377D0
(en)
|
1992-12-04 |
1993-01-27 |
Ici Plc |
Herbicides
|
|
US5521202A
(en)
|
1993-04-07 |
1996-05-28 |
Taiho Pharmaceutical Co., Ltd. |
Thiazolidine derivatives and pharmaceutical compositions containing the same
|
|
TW280812B
(https=)
|
1993-07-02 |
1996-07-11 |
Bayer Ag |
|
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
|
JPH07157681A
(ja)
|
1993-12-08 |
1995-06-20 |
Konica Corp |
有機顔料の製造方法及び有機顔料を含有する電子写真感光体
|
|
DE19500118A1
(de)
|
1994-05-18 |
1995-11-23 |
Bayer Ag |
Substituierte Diazacyclohexandi(thi)one
|
|
FR2729954B1
(fr)
|
1995-01-30 |
1997-08-01 |
Sanofi Sa |
Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
US5780466A
(en)
|
1995-01-30 |
1998-07-14 |
Sanofi |
Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
|
|
US5776959A
(en)
|
1995-06-05 |
1998-07-07 |
Washington University |
Anticonvulsant and anxiolytic lactam and thiolactam derivatives
|
|
JPH09151179A
(ja)
|
1995-11-30 |
1997-06-10 |
Canon Inc |
光学活性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた液晶装置及び表示方法
|
|
JP2000508631A
(ja)
|
1996-04-03 |
2000-07-11 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシルタンパク質トランスフェラーゼの阻害剤
|
|
CA2262502C
(en)
|
1996-07-31 |
2002-11-26 |
Nikken Chemicals Co., Ltd. |
6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
|
|
US6794390B2
(en)
|
1996-08-02 |
2004-09-21 |
Cv Therapeutics, Inc. |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
|
|
US5866702A
(en)
|
1996-08-02 |
1999-02-02 |
Cv Therapeutics, Incorporation |
Purine inhibitors of cyclin dependent kinase 2
|
|
US6159990A
(en)
|
1997-06-18 |
2000-12-12 |
Synaptic Pharmaceutical Corporation |
Oxazolidinones as α1A receptor antagonists
|
|
AU740064B2
(en)
|
1997-06-18 |
2001-10-25 |
H. Lundbeck A/S |
Heterocyclic substituted piperidines and uses thereof
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
GB9715892D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic compounds
|
|
US5936124A
(en)
|
1998-06-22 |
1999-08-10 |
Sepacor Inc. |
Fluoxetine process from benzoylpropionic acid
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
DE19929348A1
(de)
|
1999-06-26 |
2000-12-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten
|
|
US7256005B2
(en)
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
US6436928B1
(en)
|
1999-12-17 |
2002-08-20 |
Schering Corporation |
Selective neurokinin antagonists
|
|
ES2258485T3
(es)
|
1999-12-17 |
2006-09-01 |
Schering Corporation |
Antagonistas selectivos de neuroquinina.
|
|
WO2001055063A1
(en)
|
2000-01-25 |
2001-08-02 |
Idemitsu Petrochemical Co., Ltd. |
Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives
|
|
GB0003397D0
(en)
|
2000-02-14 |
2000-04-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
DE10034623A1
(de)
|
2000-07-17 |
2002-01-31 |
Bayer Ag |
Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
DE10035927A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035928A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
DE10035908A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
ES2250464T3
(es)
|
2000-08-16 |
2006-04-16 |
Neurogen Corporation |
Derivados de piridina 2,4- sustituidos.
|
|
CA2422055A1
(en)
|
2000-09-11 |
2002-03-21 |
Sepracor, Inc. |
Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
|
|
US7294637B2
(en)
|
2000-09-11 |
2007-11-13 |
Sepracor, Inc. |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
|
|
JP2002179572A
(ja)
|
2000-10-06 |
2002-06-26 |
Nikken Chem Co Ltd |
アレルギー性眼疾患治療剤
|
|
US6841671B2
(en)
|
2000-10-26 |
2005-01-11 |
Pfizer Inc. |
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
US20030143668A1
(en)
|
2001-06-18 |
2003-07-31 |
National Institute Of Advanced Industrial |
Guanosine triphosphate-binding protein coupled receptors
|
|
JP3873115B2
(ja)
|
2001-09-25 |
2007-01-24 |
独立行政法人産業技術総合研究所 |
環状ウレタン製造方法
|
|
JP4545437B2
(ja)
|
2001-10-15 |
2010-09-15 |
シェーリング コーポレイション |
アデノシンａ２ａ受容体アンタゴニストとしてのイミダゾ（４，３−ｅ）−１，２，４−トリアゾロ（１，５−ｃ）ピリミジン
|
|
MXPA04004830A
(es)
|
2001-11-22 |
2004-07-30 |
Ono Pharmaceutical Co |
Compuestos derivados de piperidin-2-ona, y composiciones farmaceuticas que los contienen como ingredientes activos.
|
|
JP2003300884A
(ja)
|
2002-04-08 |
2003-10-21 |
Nikken Chem Co Ltd |
ＴＮＦ−α産生阻害剤
|
|
EP1501834B1
(en)
|
2002-04-26 |
2005-09-07 |
Pfizer Products Inc. |
Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
|
|
WO2003091258A1
(en)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
|
|
DE60335359D1
(de)
|
2002-04-30 |
2011-01-27 |
Kudos Pharm Ltd |
Phthalazinonderivate
|
|
ATE358482T1
(de)
|
2002-07-03 |
2007-04-15 |
Schering Corp |
1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten
|
|
AU2003249812A1
(en)
|
2002-07-18 |
2004-02-09 |
Queen's University At Kingston |
Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
|
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
|
TWI347946B
(en)
|
2002-10-11 |
2011-09-01 |
Otsuka Pharma Co Ltd |
2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
|
|
GB0228410D0
(en)
|
2002-12-05 |
2003-01-08 |
Glaxo Group Ltd |
Novel Compounds
|
|
EP1581520A4
(en)
|
2002-12-13 |
2006-08-23 |
Smithkline Beecham Corp |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
CA2519939A1
(en)
|
2003-03-26 |
2004-10-14 |
Merck & Co., Inc. |
Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
|
|
US7700583B2
(en)
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ITMI20031292A1
(it)
|
2003-06-25 |
2004-12-26 |
Nikem Research Srl |
Derivati biciclici nk-2 antagonisti selettivi.
|
|
DE10358004A1
(de)
|
2003-12-11 |
2005-07-14 |
Abbott Gmbh & Co. Kg |
Ketolactam-Verbindungen und ihre Verwendung
|
|
US7186844B2
(en)
|
2004-01-13 |
2007-03-06 |
Mitsubishi Gas Chemical Co., Inc. |
Method for producing cyclic carbamate ester
|
|
JP4324669B2
(ja)
|
2004-01-21 |
2009-09-02 |
独立行政法人産業技術総合研究所 |
環状ウレタンの製造方法
|
|
JP2005239670A
(ja)
|
2004-02-27 |
2005-09-08 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
JP2007528396A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Ｈｉｖインテグラーゼ阻害薬
|
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
|
JP2005272321A
(ja)
|
2004-03-23 |
2005-10-06 |
Ono Pharmaceut Co Ltd |
含窒素複素環化合物およびその医薬用途
|
|
NZ551076A
(en)
*
|
2004-05-07 |
2009-05-31 |
Janssen Pharmaceutica Nv |
Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
GB0411404D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0414438D0
(en)
|
2004-06-28 |
2004-07-28 |
Syngenta Participations Ag |
Chemical compounds
|
|
EP1621539A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621536A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
EP1621535A1
(en)
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
US7544677B2
(en)
|
2004-08-23 |
2009-06-09 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
|
BRPI0515121A
(pt)
|
2004-08-30 |
2008-07-08 |
Janssen Pharmaceutica Nv |
derivados da n-2 adamantil-2-fenóxi acetamida como inibidores da 11-beta hidroxiesteróide desidrogenase
|
|
MY141198A
(en)
|
2004-08-30 |
2010-03-31 |
Janssen Pharmaceutica Nv |
Tricyclic adamantylamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
EP1791821B1
(en)
|
2004-09-10 |
2013-06-05 |
Janssen Pharmaceutica NV |
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
|
|
WO2006040329A1
(en)
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
AU2005296124A1
(en)
|
2004-10-13 |
2006-04-27 |
Neurogen Corporation |
Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor
|
|
CA2585797C
(en)
|
2004-11-10 |
2015-01-06 |
Incyte Corporation |
Lactam compounds and their use as pharmaceuticals
|
|
US20060167044A1
(en)
|
2004-12-20 |
2006-07-27 |
Arnaiz Damian O |
Piperidine derivatives and their use as anti-inflammatory agents
|
|
BRPI0517497A
(pt)
*
|
2004-12-23 |
2008-10-07 |
Chiesi Farma Spa |
derivados de azol com atividade antimuscarìnica
|
|
CA2590961C
(en)
|
2004-12-28 |
2013-11-26 |
Exelixis, Inc. |
[1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
JP2008528506A
(ja)
|
2005-01-19 |
2008-07-31 |
ニューロジェン・コーポレーション |
ヘテロアリール置換ピペラジニル−ピリジン類縁体
|
|
BRPI0607946A2
(pt)
|
2005-02-16 |
2009-10-20 |
Schering Corp |
piperazina-piperidinas substituìdas por pirazinila com atividade de antagonista cxcr3
|
|
CN101146793A
(zh)
|
2005-02-16 |
2008-03-19 |
先灵公司 |
具有cxcr3拮抗剂活性的新的杂环取代了的吡啶或苯基化合物
|
|
CA2598489A1
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Piperazine-piperidines with cxcr3 antagonist activity
|
|
CA2598456A1
(en)
|
2005-02-16 |
2006-08-24 |
Schering Corporation |
Heterocyclic substituted piperazines with cxcr3 antagonist activity
|
|
AU2006214378A1
(en)
|
2005-02-16 |
2006-08-24 |
Pharmacopeia, Inc. |
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
|
|
EP1853583B1
(en)
|
2005-02-16 |
2011-09-07 |
Schering Corporation |
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
KR100890886B1
(ko)
|
2005-02-24 |
2009-03-31 |
니혼노야쿠가부시키가이샤 |
신규 할로알킬설폰아닐리드 유도체, 제초제 및 이의 이용방법
|
|
US20090264650A1
(en)
|
2005-03-31 |
2009-10-22 |
Nobuo Cho |
Prophylactic/Therapeutic Agent for Diabetes
|
|
WO2007008529A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc |
Celullar cholesterol absorption modifiers
|
|
EP1924265A4
(en)
*
|
2005-08-16 |
2010-06-02 |
Genzyme Corp |
COMPOUNDS BINDING TO CHEMOKINE RECEPTORS
|
|
JP2009511582A
(ja)
|
2005-10-11 |
2009-03-19 |
シェーリング コーポレイション |
Ｃｘｃｒ３拮抗薬活性を有する置換複素環式化合物
|
|
KR20080076916A
(ko)
|
2005-11-01 |
2008-08-20 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
JP2007140188A
(ja)
|
2005-11-18 |
2007-06-07 |
Fujifilm Corp |
ポジ型感光性組成物及びそれを用いたパターン形成方法
|
|
CA2630718A1
(en)
|
2005-11-22 |
2007-05-31 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EP1957494A2
(en)
|
2005-12-05 |
2008-08-20 |
Incyte Corporation |
Lactam compounds and methods of using the same
|
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
|
DE102005062990A1
(de)
|
2005-12-28 |
2007-07-05 |
Grünenthal GmbH |
Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln
|
|
EP1973889B1
(en)
|
2005-12-30 |
2016-08-24 |
Merck Sharp & Dohme Corp. |
Cetp inhibitors
|
|
EP1971595B1
(en)
|
2005-12-30 |
2013-10-16 |
Merck Sharp & Dohme Corp. |
Cetp inhibitors
|
|
JP5192392B2
(ja)
|
2005-12-30 |
2013-05-08 |
メルク・シャープ・エンド・ドーム・コーポレイション |
コレステリルエステル転送タンパク質阻害剤
|
|
US7915271B2
(en)
|
2005-12-30 |
2011-03-29 |
Merck Sharp & Dohme Corp. |
1,3-oxazolidin-2-one derivatives useful as CETP inhibitors
|
|
WO2007084314A2
(en)
|
2006-01-12 |
2007-07-26 |
Incyte Corporation |
MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
WO2007109456A2
(en)
|
2006-03-16 |
2007-09-27 |
Pharmacopeia, Inc. |
Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
JP2007254409A
(ja)
|
2006-03-24 |
2007-10-04 |
Taisho Pharmaceut Co Ltd |
イミダゾリジノン誘導体
|
|
US7435833B2
(en)
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
EA014718B1
(ru)
|
2006-04-21 |
2011-02-28 |
Эли Лилли Энд Компани |
Производные бифениламидлактама в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы 1
|
|
AU2007240550B2
(en)
|
2006-04-21 |
2012-02-23 |
Eli Lilly And Company |
Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
US20100168103A1
(en)
|
2006-09-14 |
2010-07-01 |
Neuromed Pharmaceuticals Ltd. |
Diaryl piperidine compounds as calcium channel blockers
|
|
KR20090053923A
(ko)
|
2006-09-22 |
2009-05-28 |
노파르티스 아게 |
헤테로시클릭 유기 화합물
|
|
JP5079011B2
(ja)
|
2006-10-19 |
2012-11-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
糖尿病のための１１β−ＨＳＤ１阻害剤としてのイミダゾロン及びイミダゾリジノン誘導体
|
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
|
CA2678577A1
(en)
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
US20100104534A1
(en)
|
2007-03-23 |
2010-04-29 |
Srikanth Venkatraman |
Hydrazido-peptides as inhibitors of hcv ns3-protease
|
|
EP2183228B1
(en)
|
2007-07-26 |
2014-08-20 |
Vitae Pharmaceuticals, Inc. |
CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
|
|
JP2009110842A
(ja)
|
2007-10-31 |
2009-05-21 |
Sumitomo Chemical Co Ltd |
ボタンスイッチ被覆用積層樹脂体
|
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
CL2008003407A1
(es)
|
2007-11-16 |
2010-01-11 |
Boehringer Ingelheim Int |
Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
|
|
CA2708303A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
|
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
JP5734666B2
(ja)
|
2008-02-11 |
2015-06-17 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の１，３−オキサアゼパン−２−オン及び１，３−ジアゼパン−２−オン阻害剤
|
|
CA2711757C
(en)
|
2008-02-12 |
2016-07-26 |
Boehringer Ingelheim International Gmbh |
Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
US8598160B2
(en)
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
JP5538356B2
(ja)
|
2008-03-18 |
2014-07-02 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
|
|
AR071236A1
(es)
|
2008-05-01 |
2010-06-02 |
Vitae Pharmaceuticals Inc |
Inhibidores ciclicos de la 11beta-hidroxiesteroide deshidrogenasa 1
|
|
CL2009001059A1
(es)
|
2008-05-01 |
2010-11-12 |
Boehringer Ingelheim Int |
Compuestos derivados de 1,3-oxazin-2-ona-3,6 sustituidos, inhibidores de la actividad de la 11-beta-hidroxiesteroide deshidrogenasa i; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades tales como diabetes mellitus, entre otras.
|
|
CA2723032A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2009134387A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8765780B2
(en)
|
2008-05-13 |
2014-07-01 |
Boehringer Ingelheim International Gmbh |
Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
|
|
WO2010010149A1
(en)
|
2008-07-23 |
2010-01-28 |
Bioalliance Pharma |
Styrylquinolines, their process of preparation and their therapeutic uses
|
|
US8846668B2
(en)
|
2008-07-25 |
2014-09-30 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2010011314A1
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
|
|
CA2730208C
(en)
|
2008-07-25 |
2016-10-25 |
Boehringer Ingelheim International Gmbh |
1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
|
|
CA2735204C
(en)
|
2008-08-25 |
2017-06-20 |
Boehringer Ingelheim International Gmbh |
Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
AR073920A1
(es)
|
2008-10-23 |
2010-12-09 |
Boehringer Ingelheim Int |
Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
|
|
JP5589003B2
(ja)
|
2009-02-04 |
2014-09-10 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
脂質障害のような代謝疾患の処置のために有用な［１，３］オキサジン−２−オンの誘導体
|
|
KR20120061771A
(ko)
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|